GDNF and amyotrophic lateral sclerosis: Thus, it was shown that genetically modified human mesenchymal stem cells, simultaneously overexpressing GDNF and VEGF, when injected intramuscularly into rats with a model of amyotrophic lateral sclerosis (ALS), maintain the neuromuscular synapse structure and prolong animal life [63].